Becton, Dickinson and Company (NYSE:BDX) Receives $280.00 Consensus PT from Brokerages

Becton, Dickinson and Company (NYSE:BDX) has been assigned a consensus rating of “Moderate Buy” from the five research firms that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $281.40.

Separately, Barclays boosted their price target on Becton, Dickinson and Company from $305.00 to $312.00 and gave the company an “overweight” rating in a research report on Monday.

Becton, Dickinson and Company Price Performance

Shares of NYSE BDX opened at $235.00 on Friday. The company has a current ratio of 1.41, a quick ratio of 0.97 and a debt-to-equity ratio of 0.62. The stock has a market cap of $67.92 billion, a P/E ratio of 51.76, a P/E/G ratio of 1.92 and a beta of 0.45. The stock has a 50 day moving average of $238.16 and a two-hundred day moving average of $239.93. Becton, Dickinson and Company has a twelve month low of $229.40 and a twelve month high of $287.32.

Becton, Dickinson and Company (NYSE:BDX) last issued its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $3.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.97 by $0.20. The firm had revenue of $5.05 billion during the quarter, compared to analysts’ expectations of $5.04 billion. Becton, Dickinson and Company had a net margin of 6.76% and a return on equity of 13.90%. Becton, Dickinson and Company’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.86 EPS. On average, research analysts forecast that Becton, Dickinson and Company will post 13.04 earnings per share for the current year.

Becton, Dickinson and Company Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Monday, June 10th will be paid a dividend of $0.95 per share. This represents a $3.80 dividend on an annualized basis and a dividend yield of 1.62%. The ex-dividend date of this dividend is Monday, June 10th. Becton, Dickinson and Company’s dividend payout ratio (DPR) is 83.70%.

Insider Activity at Becton, Dickinson and Company

In other Becton, Dickinson and Company news, SVP Thomas J. Spoerel sold 282 shares of the stock in a transaction on Thursday, March 14th. The stock was sold at an average price of $238.29, for a total value of $67,197.78. Following the completion of the transaction, the senior vice president now owns 2,276 shares in the company, valued at $542,348.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, EVP Michael David Garrison sold 1,715 shares of the firm’s stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $232.81, for a total value of $399,269.15. Following the completion of the transaction, the executive vice president now directly owns 5,381 shares of the company’s stock, valued at approximately $1,252,750.61. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Thomas J. Spoerel sold 282 shares of the business’s stock in a transaction on Thursday, March 14th. The stock was sold at an average price of $238.29, for a total value of $67,197.78. Following the sale, the senior vice president now owns 2,276 shares in the company, valued at $542,348.04. The disclosure for this sale can be found here. Company insiders own 0.31% of the company’s stock.

Institutional Investors Weigh In On Becton, Dickinson and Company

Institutional investors and hedge funds have recently made changes to their positions in the business. OFI Invest Asset Management purchased a new stake in shares of Becton, Dickinson and Company in the third quarter valued at about $25,000. Livelsberger Financial Advisory acquired a new stake in Becton, Dickinson and Company during the 4th quarter valued at $27,000. OLD Point Trust & Financial Services N A purchased a new position in Becton, Dickinson and Company during the fourth quarter worth $29,000. DiNuzzo Private Wealth Inc. acquired a new position in shares of Becton, Dickinson and Company in the fourth quarter worth $30,000. Finally, Scarborough Advisors LLC purchased a new stake in shares of Becton, Dickinson and Company in the fourth quarter valued at $32,000. 86.97% of the stock is currently owned by hedge funds and other institutional investors.

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.